retatrutide drug retatrutide clinical trials Phase 3: 60% Achieved Surgical-Level Weight Loss A New Obesity Drug Delivered

A sore throat accompanied by fever, difficulty swallowing, or respiratory symptoms warrants medical evaluation to rule out infection or other conditions requiring specific treatment

A published usability study on the now-marketed high-dose, 2.0 mL format reported no new product technical issues or no new safety concerns compared with the 1.0 mL autoinjector format marketed previously

"FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice." Aging

Although the exact mechanism of the difference in male and female GST gene induction still remains unknown, differences in GST activity have been observed previously in mosquitoes [20]